Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,365 | -41,443 | -27,936 | -17,132 | N/A |
| Depreciation Amortization | 670 | 490 | 549 | 257 | N/A |
| Accounts payable and accrued liabilities | 1,569 | -2,323 | 2,282 | 23 | N/A |
| Other Working Capital | 1,439 | -6,392 | 7,036 | 556 | N/A |
| Other Operating Activity | 4,541 | 20,637 | 414 | 249 | 0 |
| Operating Cash Flow | $-39,146 | $-29,031 | $-17,655 | $-16,047 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -437 | -581 | -209 | -771 | N/A |
| Purchase Of Investment | -150,961 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 14,400 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-136,998 | $-581 | $-209 | $-771 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 33,000 | 10,000 | N/A | N/A |
| Debt Repayment | -48 | -108 | -97 | -62 | N/A |
| Common Stock Issued | 299,903 | 83,804 | 3 | 5 | N/A |
| Common Stock Repurchased | -132 | N/A | N/A | -4 | N/A |
| Other Financing Activity | -36 | -225 | -269 | -59 | 0 |
| Financing Cash Flow | $299,687 | $116,471 | $9,637 | $-120 | $N/A |
| Beginning Cash Position | 88,394 | 1,535 | 9,762 | 26,700 | N/A |
| End Cash Position | 211,937 | 88,394 | 1,535 | 9,762 | N/A |
| Net Cash Flow | $123,543 | $86,859 | $-8,227 | $-16,938 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,146 | -29,031 | -17,655 | -16,047 | N/A |
| Capital Expenditure | -437 | -581 | -209 | -771 | N/A |
| Free Cash Flow | -39,583 | -29,612 | -17,864 | -16,818 | 0 |